Panacea-GenomeScreen
Pre-clinical- Indications
- IVF genetic screening
Company intelligence / Profile preview
Juniper Genomics has developed a proprietary genomic test that screens for over 1000 known genetic causes of IVF cycle failure or pregnancy loss. Their technology integrates whole genome and transcriptome sequencing with advanced data analytics to improve the accuracy of embryo selection, aiming to increase the success rate of first-time embryo transfers in IVF. The company’s approach addresses limitations of current euploid embryo testing by leveraging more comprehensive datasets. Clinical results have demonstrated feasibility since 2021.
3 more assets in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Juniper Genomics.